Skip to main content

Find Clinical Trials

Home
Conditions
Japanese Encephalitis Virus Disease

Clinical trial condition

Japanese Encephalitis Virus Disease

Explore clinical trials studying Japanese Encephalitis Virus Disease. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Japanese Encephalitis Virus Disease trial results

Recruiting

A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults

NCT06680128

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Nucleus Network - Brisbane (Q Pharm) Brisbane, Australia

Nucleus Network - Melbourne Melbourne, Australia

New Zealand Clinical Research Christchurch, Central City, New Zealand

View Trial Details

Completed

Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in Toddlers

NCT01396512

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +18 more
Locations: Goyang, South Korea

Incheon, South Korea

Seongnam, South Korea

Seoul, South Korea

View Trial Details